Subsequently, the postoperative pathology reveals the presence of monophasic synovial sarcoma, specifically confirmed by positive expression of Vimentin, TLE1, and BCL-2 in immunohistochemical analysis. This evidence concerns the gene BCL2 and synovial sarcoma.